CIRM Approves $5.8 million grant for CAR-T therapy that targets cancer stem cells

(University of California - San Diego) The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved a $5.8 million award to University of California San Diego School of Medicine researchers to develop a new immunotherapy in which patients' cells would be equipped with a special receptor that recognizes and targets cancer stem cells, whose survival abilities often render standard therapies ineffective or short-term. (Source: EurekAlert! - Cancer)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2vp7X6T
via IFTTT